Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
25.01
67.66
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Guangzhou Kingmed Diagnostics Group Co Ltd
Guangzhou Kingmed Diagnostics Group Co Ltd
Cash & Cash Equivalents
Guangzhou Kingmed Diagnostics Group Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Cash & Cash Equivalents
¥1.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
Cash & Cash Equivalents
¥1.3B
|
CAGR 3-Years
73%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
|
|
Topchoice Medical Co Inc
SSE:600763
|
Cash & Cash Equivalents
¥622.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Cash & Cash Equivalents
¥4.6B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
17%
|
|
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Cash & Cash Equivalents
¥1.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
17%
|
CAGR 10-Years
27%
|
|
|
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Cash & Cash Equivalents
¥1.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
29%
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
Glance View
Guangzhou Kingmed Diagnostics Group Co., Ltd. engages in the provision of outsourced medical examination and pathological diagnosis services to medical institutions. The company is headquartered in Guangzhou, Guangdong and currently employs 12,371 full-time employees. The company went IPO on 2017-09-08. The firm is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.
See Also
What is Guangzhou Kingmed Diagnostics Group Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.8B
CNY
Based on the financial report for Sep 30, 2024, Guangzhou Kingmed Diagnostics Group Co Ltd's Cash & Cash Equivalents amounts to 1.8B CNY.
What is Guangzhou Kingmed Diagnostics Group Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
17%
Over the last year, the Cash & Cash Equivalents growth was -57%. The average annual Cash & Cash Equivalents growth rates for Guangzhou Kingmed Diagnostics Group Co Ltd have been -2% over the past three years , 17% over the past five years .
You don't have any saved screeners yet
